Trump Administration Proposes MFN Deals in Pharmacy Sector
Explore the Trump administration's proposal on MFN agreements affecting pharmaceutical pricing and the ongoing regulatory developments in healthcare.
Explore the Trump administration's proposal on MFN agreements affecting pharmaceutical pricing and the ongoing regulatory developments in healthcare.
Explore key legislative changes in Kansas impacting health policy and the insurance industry, including Medicaid reforms and new pharmacist roles. Stay informed!
Medicare Part D reimbursement changes risk closure of 60% of Arizona's long-term care pharmacies, impacting medication access for thousands of elderly Medicare beneficiaries. Legislative and administrative actions are being proposed to address the crisis.
Independent U.S. pharmacies leverage Medicare Advantage OTC benefits to diversify revenue and enhance patient care amid rising healthcare costs and reimbursement challenges.
Michigan pharmacist sentenced to 46 months for $4M Medicare fraud involving phantom prescriptions. DOJ Health Care Fraud Strike Force prosecuted the case.
Kinney Drugs and EnlivenHealth collaborate to assist seniors with free Medicare Part D plan comparisons during the open enrollment period ending December 7. Over 460 stand-alone PDPs and numerous Medicare Advantage plans make enrollment decisions complex.
Bipartisan bill reintroduced to authorize Medicare payments for pharmacists providing basic medical services in underserved and rural areas, enhancing healthcare access for seniors.
The Medicare LI NET program provides temporary prescription drug coverage without restrictions to low income beneficiaries not yet enrolled in a Part D plan, ensuring seamless access during the transition period.
Clover Health partners with IPC Digital Health to launch a community pharmacy pilot in New Jersey, leveraging AI and local pharmacists to improve medication adherence and health outcomes for Medicare Advantage members.
Pennsylvania Senate passes Bill 95 with amendment requiring pharmacies to disclose retail and generic drug prices upon consumer request, promoting prescription drug cost transparency and informed purchasing decisions.